Time to Viral Load Suppression and Its Predictors Among Adult Patients on Antiretro Viral Therapy in Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Hossana, Southern Ethiopia-Reference-Cited by-同舟云学术

Time to Viral Load Suppression and Its Predictors Among Adult Patients on Antiretro Viral Therapy in Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Hossana, Southern Ethiopia

Published:2023-04 Issue: Volume:Volume 15 Page:157-171
ISSN:1179-1373
Container-title:HIV/AIDS - Research and Palliative Care
language:en
Short-container-title:HIV

Author:

Erjino Eshetu,Abera Ermias^ORCID,Lemma Tirore Lire^ORCID

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Dermatology,Health Policy,Epidemiology

Reference27 articles.

1. Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

2. UNAIDS. 90-90-90 an Ambitious Treatment Target to Help End the AIDS Epidemic. Geneva, Switzerland: UNAIDS; 2017.

3. Ministry of Health E. National Consolidated Guidelines for Comprehensive HIV Prevention, Care and Treatment. Addis Ababa: MoH; 2018.

4. UNAIDS. Fact sheet - global HIV statistics; 2021. Available from: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf. Accessed April 17, 2023.

5. UNAIDS. UNAIDS DATA 2017. UNAIDS; 2017. Available from: https://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf. Accessed April 17, 2023.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Viral Non-Suppression and Its Associated Factors Among PMTCT Mothers Receiving ARV Treatment in Ethiopia;2024-06-14

2. Actualización sobre las pruebas diagnósticas de la infección por el virus de la inmunodeficiencia humana en gestantes;Revista Peruana de Ginecología y Obstetricia;2024-04-03

3. Virological Suppression and its Predictors Among HIV/AIDS Patients on Antiretroviral Therapy in Ethiopia: Systematic Review and Meta-analysis;Open Forum Infectious Diseases;2024-03-21

4. Relationship Between Tenofovir Diphosphate Concentrations in Dried Blood Spots and Virological Outcomes After Initiating Tenofovir–Lamivudine–Dolutegravir as First-Line or Second-Line Antiretroviral Therapy;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-03-01

5. Prevalence and predictors of persistent low-level HIV viraemia: a retrospective cohort study among people receiving dolutegravir-based antiretroviral therapy in Southern Nigeria;Therapeutic Advances in Infectious Disease;2024-01